PPS
Burlington, US · 2 known investors
ProtaGene provides molecular bioanalytical services for gene therapy development, specializing in biodistribution studies, transgene expression assessment, and vector shedding analysis to support preclinical safety evaluation and clinical development of viral vector-based therapies.
Founders & leadership
Investors · 2
In the news
PPS Board member raises TIF concerns at city council meetingyahoo.com · Aug 2026
PPS 150 sees $9M increase in evidence-based funding as district considers ‘third-party’ audit help | WCBU Peoriawcbu.org · Aug 2026Frequently asked questions
- What does PPS do?
- ProtaGene provides molecular bioanalytical services for gene therapy development, specializing in biodistribution studies, transgene expression assessment, and vector shedding analysis to support preclinical safety evaluation and clinical development of viral vector-based therapies.
- Who are PPS's investors?
- PPS's investors include Ampersand, D11Z.
- Where is PPS headquartered?
- PPS is headquartered in Burlington, US.